Viewing StudyNCT00079820



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00079820
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2004-03-15

Brief Title: Safety Tolerability and Immune Response of ACAM3000 Modified Vaccinia Ankara MVA Smallpox Vaccine in Adults
Sponsor: Sanofi Pasteur a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Smallpox
Keywords:
Name View
Protection against smallpox View
Smallpox View
Smallpox Vaccine View
Variola virus View
Smallpox Virus View
MODIFIED VACCINIA ANKARA View
MVA View
Dryvax View
Dryvax vaccine View